Mary Carrington PhD
Dr. Mary Carrington is the Director of the Basic Science Program at the Frederick National Laboratory for Cancer Research (FNLCR), where she is responsible for the guidance and oversight of a large, diverse group of scientists performing investigator-initiated hypothesis-driven basic research in cancer and AIDS. She is also a senior Principal Scientist and heads the HLA Immunogenetics Laboratory within the Cancer and Inflammation Program of the National Cancer Institute. Dr. Carrington is a Steering Committee member of the Ragon Institute of MGH, MIT, and Harvard. Her primary research interests focus on the role of host genetics in cancer, autoimmunity and infectious disease pathogenesis.
Dr. Carrington graduated from The University of Kansas with a B.S. in Education, later obtaining her M.S. and Ph.D. in Immunobiology from Iowa State University. She performed her postdoctoral studies in the departments of Immunology and Microbiology at Duke University and the University of North Carolina, after which she joined the Immunology Department at Duke University as a faculty member. She moved to the National Cancer Institute at Frederick (NCI-Frederick), now the FNLCR, in 1989.